GUARDANT HEALTH, INC. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 18,1 USD | +4,38% |
|
+10,43% | -33,09% |
Grafiek agenda Guardant Health, Inc.
28dc2c0897057a3d34e98bc1d14673.nTZOBFkRt_j3zX9tm0B7VF3cIpWQD-EptLXZW2wdpms.-GIqbyBe2M61mQop6gUSIAnrdM_AeIgc0OaNKSNRlwP4WSVLHVCBqKGLSw~7e01ba4aec814b441e93a1c7d9344816
Komende gebeurtenissen op Guardant Health, Inc.
Gebeurtenissen op naam
| 09-04-2024 00:05 | American Association for Cancer Research Meeting - Poster No: 3888 |
| 08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No: 3499/21 |
| 08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No: 3399/1 |
| 08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No: 3670/15 |
| 08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No: 2490/7 |
| 08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No: 2390/5 |
| 08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No: 2420/16 |
| 07-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No: 969/10 |
| 07-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No: 406/6 |
| 05-03-2024 15:50 | TD Cowen Health Care Conference - Fireside Chat |
| 29-02-2024 19:00 | Citi Unplugged Medtech and Life Sciences Access Day - Fireside Chat |
| 22-02-2024 22:30 | Q4 2023 Presentatie van de resultaten |
| 22-02-2024 22:05 | Q4 2023 Cijferpublicaties |
| 18-01-2024 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No 70 |
| 18-01-2024 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No 69 |
| 18-01-2024 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No 276 |
| 18-01-2024 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No 455 |
| 18-01-2024 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No 158 |
| 18-01-2024 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No 170 |
| 18-01-2024 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No181 |
Geschiedenis van de jaarlijkse publicaties
| Start boekjaar | december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Omzet Miljoen USD | Gepubliceerd Verwachting Spread | 214 206 3.92% | 287 285 0.6% | 374 365 2.42% | 450 446 0.68% | 564 560 0.75% | 664 |
|
EBITDA Miljoen USD | Gepubliceerd Verwachting Spread | -71,0 -76,5 7.27% | -85,2 -203 57.96% | -389 -352 -10.51% | -499 -440 -13.4% | -436 -399 -9.3% | -336 |
|
Bedrijfsresultaat (EBIT) Miljoen USD | Gepubliceerd Verwachting Spread | -82,4 -86,3 4.57% | -255 -218 -16.79% | -411 -442 6.96% | -544 -535 -1.66% | -565 -478 -18.25% | -404 |
|
Resultaat voor belastingen (EBT) Miljoen USD | Gepubliceerd Verwachting Spread | -69,7 -73,7 5.4% | -246 -211 -16.59% | -384 -421 8.61% | -653 -625 -4.55% | -479 -398 -20.37% | -399 |
|
Nettowinst (verlies) Miljoen USD | Gepubliceerd Verwachting Spread | -75,7 -78,6 3.8% | -254 -218 -16.41% | -406 -445 8.89% | -655 -638 -2.53% | -479 -402 -19.41% | -399 |
|
WPA USD | Gepubliceerd Verwachting Spread | -0,84 -0,88 4.98% | -2,60 -2,19 -18.61% | -4,00 -4,37 8.55% | -6,41 -6,33 -1.34% | -4,28 -3,62 -18.23% | -3,35 |
| Datum van publicatie | 24/02/20 | 24/02/21 | 23/02/22 | 23/02/23 | 22/02/24 | - |
Geschiedenis van de driemaandelijkse publicaties
| Start boekjaar | december | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Omzet Miljoen USD | Gepubliceerd Verwachting Spread | 108 98,7 9.51% | 96,1 95,7 0.41% | 109 105 3.81% | 117 118 -0.42% | 127 124 2.39% | 129 118 9.32% | 137 129 5.98% | 143 137 4.11% | 155 151 2.83% | 150 | 161 | 168 | 184 | 181 |
|
EBITDA Miljoen USD | Gepubliceerd Verwachting Spread | -92,1 -98,3 6.25% | -112 -107 -4.52% | -120 -115 -4.69% | -123 -118 -3.97% | -133 -118 -13.4% | -123 -113 -9.61% | -108 -105 -3.22% | -102 -94,5 -7.73% | -103 -86,6 -18.78% | -88,4 | -100 | -82,9 | -78,0 | -78,0 |
|
Bedrijfsresultaat (EBIT) Miljoen USD | Gepubliceerd Verwachting Spread | -98,2 -119 17.21% | -123 -122 -0.99% | -130 -125 -4.34% | -145 -130 -10.89% | -146 -141 -3.72% | -134 -142 5.34% | -120 -127 5.48% | -114 -117 2.82% | -198 -109 -81.32% | -110 | -105 | -101 | -95,8 | -105 |
|
Resultaat voor belastingen (EBT) Miljoen USD | Gepubliceerd Verwachting Spread | -72,3 -110 34.33% | -123 -127 2.82% | -229 -133 -71.83% | -162 -135 -20.15% | -139 -144 2.94% | -133 -141 5.69% | -72,3 -126 42.66% | -85,6 -116 25.98% | -188 -104 -79.58% | -108 | -106 | -103 | -98,6 | -110 |
|
Nettowinst (verlies) Miljoen USD | Gepubliceerd Verwachting Spread | -90,9 -118 22.87% | -123 -128 3.85% | -229 -128 -78.58% | -162 -132 -22.81% | -140 -145 3.37% | -134 -137 2.33% | -72,8 -127 42.61% | -86,1 -112 22.87% | -187 -103 -82.05% | -108 | -103 | -101 | -96,6 | -104 |
|
WPA USD | Gepubliceerd Verwachting Spread | -0,89 -1,15 22.46% | -1,21 -1,23 1.63% | -2,25 -1,21 -85.35% | -1,58 -1,28 -23.03% | -1,36 -1,40 2.91% | -1,30 -1,29 -0.92% | -0,67 -1,21 44.8% | -0,73 -0,97 24.52% | -1,58 -0,88 -79.51% | -0,90 | -0,86 | -0,84 | -0,80 | -0,85 |
| Datum van publicatie | 23/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 09/05/23 | 03/08/23 | 06/11/23 | 22/02/24 | - | - | - | - | - |
| 27-04-2024 | BGI GENOMICS CO., LTD.: Q1 2024 Cijferpublicaties |
| 02-05-2024 | CAREDX, INC: Q1 2024 Cijferpublicaties (schatting) |
| 07-05-2024 | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Cijferpublicaties (schatting) |
| 07-05-2024 22:05 | VERACYTE, INC.: Q1 2024 Cijferpublicaties |
| 08-05-2024 22:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Cijferpublicaties |
| 08-05-2024 22:05 | EXACT SCIENCES CORPORATION: Q1 2024 Cijferpublicaties |
| 09-05-2024 22:05 | GUARDANT HEALTH, INC.: Q1 2024 Cijferpublicaties |
| 13-05-2024 | SEEGENE, INC.: Q1 2024 Cijferpublicaties (schatting) |
| 30-07-2024 | VERACYTE, INC.: Q2 2024 Cijferpublicaties (schatting) |
| 30-07-2024 | EXACT SCIENCES CORPORATION: Q2 2024 Cijferpublicaties (schatting) |
Gebeurtenissen in het verleden in de sector Guardant Health, Inc.
| 13-04-2024 | BGI GENOMICS CO., LTD.: Q4 2023 Cijferpublicaties |
| 28-02-2024 22:05 | CAREDX, INC: Q4 2023 Cijferpublicaties |
| 28-02-2024 22:01 | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Cijferpublicaties |
| 22-02-2024 22:05 | VERACYTE, INC.: Q4 2023 Cijferpublicaties |
| 22-02-2024 22:05 | GUARDANT HEALTH, INC.: Q4 2023 Cijferpublicaties |
| 22-02-2024 22:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q4 2023 Cijferpublicaties |
| 21-02-2024 22:05 | EXACT SCIENCES CORPORATION: Q4 2023 Cijferpublicaties |
| 16-02-2024 | SEEGENE, INC.: Q4 2023 Cijferpublicaties |
| 10-11-2023 | SEEGENE, INC.: Q3 2023 Cijferpublicaties |
| 09-11-2023 22:05 | ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q3 2023 Cijferpublicaties |
